FDA probe of Abbott facility finds quality control issues

[March 24, 2022]  (Reuters) -An inspection at the Abbott Laboratories facility in Sturgis, Michigan found a harmful bacteria called Cronobacter sakazakii on the surface of some areas producing its powdered baby formula, the U.S. health regulator said on Tuesday.

Complaints that the facility's products had caused bacterial infections forced Abbott to recall certain Alimentum, Similac and EleCare baby formulas last month, prompting a probe from the U.S. Food and Drug Administration (FDA).

The inspection from Jan. 31 to March 18 showed https://www.fda.gov/media/
157073/download?utm_medium=email&utm_
source=govdelivery that Abbott did not have a control system covering all stages of processing to prevent microbe contamination of infant formula.

Personnel working with infant formula also did not wear necessary protective apparel, the FDA said.

"We're taking this very seriously and are working closely with the FDA to implement corrective actions," Abbott said in a statement.

 Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange (NYSE) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid

No Cronobacter sakazakii was found during the company's testing of products that were distributed to consumers, Abbott added.

The company also said that the genetic makeup of the Cronobacter sakazakii found at the Michigan plant did not match that of the reported cases.

Cronobacter sakazakii bacteria can cause serious invasive infections and premature infant death.

(Reporting by Manojna Maddipatla and Mrinalika Roy in Bengaluru; Editing by Devika Syamnath and Amy Caren Daniel)

[© 2022 Thomson Reuters. All rights reserved.]  This material may not be published, broadcast, rewritten or redistributed.  Thompson Reuters is solely responsible for this content.